Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Serum Prokineticin-2 and Calprotectin as Potential Biomarkers of Disease Stage and Focal Organ Involvement in Human Brucellosis: A Prospective Case–Control Study
- 1Department of Infectious Diseases and Clinical Microbiology, Erzurum City Hospital, Erzurum 25240, Türkiye
- 2Department of Medical Biochemistry, Faculty of Medicine, , Erzurum 25240, Türkiye
Related
- Circulating calprotectin and S100A8/A9-related biomarkers for diagnosis and prognostic stratification in adult acute infection and sepsis: a systematic review and meta-analysis.
- Plasma calprotectin as infection biomarker in hip fracture patients: a prospective cohort study.
- Serial fecal calprotectin as a screening tool for subclinical ileitis in patients with idiopathic uveitis or scleritis: a prospective cohort study
- Chronic exposure to the tire-wear contaminant 6-PPDQ induces senescence-associated biomarkers and neurobehavioral deficits: Involvement of ABL1-p53-autophagy signaling
- Early warning and risk assessment of cardiac involvement in dermatomyositis/polymyositis: from biomarkers to multimodal imaging
BibTeX
@article{cinislioglu2026serum,
title = {{Serum Prokineticin-2 and Calprotectin as Potential Biomarkers of Disease Stage and Focal Organ Involvement in Human Brucellosis: A Prospective Case–Control Study}},
author = {Nazan Cinislioğlu and Nurdan Pür and Murat Daşhan and Nurinnisa Öztürk},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703040},
note = {CC BY},
}
RIS
TY - JOUR
TI - Serum Prokineticin-2 and Calprotectin as Potential Biomarkers of Disease Stage and Focal Organ Involvement in Human Brucellosis: A Prospective Case–Control Study
AU - Nazan Cinislioğlu
AU - Nurdan Pür
AU - Murat Daşhan
AU - Nurinnisa Öztürk
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13703040
SN - 2075-4418
ER -